The American Journal of Medicine
Volume 123, Issue 7 , Pages 583-592 , July 2010

The Diagnosis of Gastroesophageal Reflux Disease

  • Brian E. Lacy, PhD, MD

      Affiliations

    • Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • Corresponding Author InformationReprint requests should be addressed to Brian E. Lacy, PhD, MD, Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Area 4C, Lebanon, NH 03756
    • ,
  • Kirsten Weiser, MD, MPh

      Affiliations

    • Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Jocelyn Chertoff, MD, MS

      Affiliations

    • Division of Radiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Ronnie Fass, MD

      Affiliations

    • Southern Arizona VA Health Care System, Tucson
    • ,
  • John E. Pandolfino, MD

      Affiliations

    • Northwestern University Feinberg School of Medicine, Chicago, Ill
    • ,
  • Joel E. Richter, MD

      Affiliations

    • Temple University School of Medicine, Philadelphia, Pa
    • ,
  • Richard I. Rothstein, MD

      Affiliations

    • Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Chad Spangler, MD

      Affiliations

    • Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Michael F. Vaezi, MD, PhD, MSc

      Affiliations

    • Vanderbilt University Medical Center, Nashville Tenn

References 

  1. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128–2138
  2. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456
  3. Locke GR, Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106:642–649
  4. Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut. 2003;52:1085–1089
  5. Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–29
  6. Wong WM, Lai KC, Hui WM, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther. 2003;18:595–604
  7. Ruigomez A, Garcia-Rodriguez LA, Wallander M-A, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther. 2004;20:751–760
  8. Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease. Pharm Res. 2001;18:1367–1372
  9. Wong WM, Lai KC, Hui WM, et al. Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study. Aliment Pharmacol Ther. 2004;20:803–812
  10. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut. 1999;44:S1–S16
  11. Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults-update 2004. Can J Gastroenterol. 2005;19:15–35
  12. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190–200
  13. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastro-esophageal reflux disease (GERD)-a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–2000
  14. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383–1391
  15. Dent J, Dodds WJ, Friedman RH, et al. Mechanisms of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980;65:256–267
  16. Kahrilas PJ. Gastroesophageal reflux disease. New Engl J Med. 2008;359:1700–1707
  17. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211
  18. Zheng Z, Margolis KL, Liu S, et al. Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology. 2008;135:72–81
  19. Dimenas E, Glise H, Hallerback B, et al. Quality of life in patients with upper gastrointestinal symptoms (An improved evaluation of treatment regimens?). Scand J Gastroenterol. 1993;28:681–687
  20. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998;104:252–258
  21. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511
  22. Levin TR, Schmittdiel JA, Kunz K, et al. Costs of acid-related disorders to a health maintenance organization. Am J Med. 1997;103:520–528
  23. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl J Med. 1999;340:825–831
  24. Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric treatment-prompt endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003;17:1481–1491
  25. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia?. JAMA. 2006;295:1566–1576
  26. Numans ME, de Wit NJ. Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastroesophageal reflux disease questionnaire. Aliment Pharmacol Ther. 2003;17:1049–1055
  27. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–208
  28. Moayyedi P, Axon ATR. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastro-oesphageal reflux disease. Am J Gastroenterol. 1999;94:3122–3125
  29. Garcia-Rodriguez LA, Wallender M, Johansson S, et al. Natural history of chest pain in GERD. Gut. 2005;54(Suppl VII):A75;OP-G-325
  30. El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in US military veterans. Gastroenterology. 1997;113:755–760
  31. Gislason T, Janson C, Vermiere P, et al. Respiratory symptoms and nocturnal gastro-oesophageal reflux: a population based study of young adults in three European countries. Chest. 2002;121:158–163
  32. Cremonini F, Wise J, Moayyedi P, Talley N. Diagnostic and therapeutic use of PPIs in non-cardiac chest pain: a meta analysis. Am J Gastroenterol. 2005;100:1226–1232
  33. Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev. 2003;(1):CD001496
  34. Chang AB, Lasserson TJ, Gaffney J, et al. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2006;(4):CD004823
  35. Lacy BE, Cash BD. A 32-year-old woman with chronic abdominal pain. JAMA. 2008;299:555–565
  36. Fass R, Ofmann JJ, Gralnek IM, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med. 1999;159:2161–2168
  37. Greatorex RA, Thorpe JA. Clinical assessment of gastro-oesophageal reflux by questionnaire. Br J Clin Pract. 1983;37:133–135
  38. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994;69:539–547
  39. Carlsson R, Dent Y, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–1029
  40. Shaw M, Talley NJ, Beebe T, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:52–57
  41. Elola-Olaso M, Rey C, Rodriguez-Artalejo E, et al. Adaptation and validation of a gastroesophageal reflux questionnaire for use on a Spanish population. Revista Espanola de Enfermedades Digestivas. 2002;94:745–758
  42. Wong WM, Lam KF, Lai KC, et al. A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-esophageal reflux disease in the Chinese population. Aliment Pharmacol Ther. 2003;17:1407–1413
  43. Wang JH, Luo JY, Dong L, et al. Composite score of reflux symptoms in diagnosis of gastroesophageal reflux disease. World J Gastroenterol. 2004;10:3332–3335
  44. Chinese Study Group. Value of reflux diagnostic questionnaire in the diagnosis of gastroesophageal reflux disease. Chinese J Dig Dis. 2004;5:51–55
  45. Zimmerman J. Validation of a brief inventory for diagnosis and monitoring of symptomatic gastroesophageal reflux. Scand J Gastroenterol. 2004;39:212–216
  46. Shimoyama Y, Kusano M, Sugimoto S, et al. Diagnosis of gastroesophageal reflux disease using a new questionnaire. J Gastroenterol Hepatol. 2005;20:643–647
  47. Horowitz N, Moshkowitz M, Halpern Z, Leshno M. Applying data mining techniques in the development of a diagnostic questionnaire for GERD. Dig Dis Sci. 2007;52:1871–1878
  48. Ho KY, Gwee KA, Khor JL, et al. Validation of a graded response questionnaire for the diagnosis of gastroesophageal reflux disease in an Asian primary care population. J Clin Gastroenterol. 2008;42:680–686
  49. Kinekawa F, Kubo F, Matsuda K, et al. Is the questionnaire for the assessment of gastroesophageal reflux useful for diabetic patients?. Scand J Gastroenterol. 2005;40:1017–1020
  50. Hung CS, Lee CL, Yang JN, et al. Clinical application of Carlsson's questionnaire to predict erosive GERD among healthy Chinese. J Gastro Hepatol. 2005;20:19001095
  51. Creteur V, Thoeni RF, Federle MP, et al. The role of single and double-contrast radiography in the diagnosis of reflux esophagitis. Radiology. 1983;147:71–75
  52. Dibble C, Levine MS, Rubesin SE, et al. Detection of reflux esophagitis on double-contrast esophagrams and endoscopy using the histologic findings as the gold standard. Abdom Imaging. 2004;29:421–425
  53. Ott DJ. Gastroesophageal reflux: what is the role of barium studies?. AJR Am J Roentgenol. 1994;162:627–629
  54. Thompson JK, Koehler RE, Richter JE. Detection of gastroesophageal reflux: value of barium studies compared with 24-hr pH monitoring. Am J Roentgenol. 1994;162:621–626
  55. Pan JJ, Levine MS, Redfern RO, et al. Gastroesophageal reflux: comparison of barium studies with 24-h pH monitoring. Eur J Radiol. 2003;47:149–153
  56. Chen MY, Ott DJ, Sinclair JW, et al. Gastroesophageal reflux disease: correlation of esophageal pH testing and radiographic findings. Radiology. 1992;185:483–486
  57. Levine MS, Chu P, Furth EE, et al. Carcinoma of the esophagus and esophagogastric junction: sensitivity of radiographic diagnosis. Am J Roentgenol. 1997;168:1423–1426
  58. Levine MS, Rubesin SE, Laufer I. Barium esophagography: a study for all seasons. Clin Gastroenterol Hepatol. 2008;6:11–25
  59. Baker ME, Einstein DM, Herts BR, et al. Gastroesophageal reflux disease: integrating the barium esophagram before and after antireflux surgery. Radiology. 2007;243:329–339
  60. Lind T, Havelund T, Carlsson R, et al. Heartburn without esophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997;32:974–979
  61. Mantynen T, Farkkila M, Kunnamo I, et al. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol. 2002;97:2524–2529
  62. Richter JE. Severe reflux esophagitis. Gastrointest Endosc Clin N Am. 1994;4:677–697
  63. Giannini EG, Zentilin P, Dulbecco P, et al. Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment. Am J Gastroenterol. 2008;103:267–275
  64. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180
  65. Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med. 1995;333:1106–1110
  66. Sharma P, Wani S, Bansai A, et al. A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:454–464
  67. Amano Y, Yamashita H, Koshino K, et al. Does magnifying endoscopy improve the diagnosis of erosive esophagitis?. J Gastroenterol Hepatol. 2008;23:1063–1068
  68. Pandolfino JE, Kahrilas PJ. AGA technical review: clinical use of esophageal manometry. Gastroenterology. 2005;128:209–224
  69. Lacy BE, Paquette L, Robertson DJ, et al. The clinical utility of esophageal manometry. J Clin Gastroenterol. 2009 March 17;[Epub ahead of print]
  70. Kahrilas PJ, Sifrim D. High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology. 2008;135:756–769
  71. Spencer J. Prolonged pH recording in the study of gastro-oesophageal reflux. Br J Surg. 1969;56:912–914
  72. Johnson LF, DeMeester TR. Twenty-four hour pH monitoring of the distal esophagus (A quantitative measure of gastroesophageal reflux). Am J Gastroenterol. 1974;62:325–332
  73. Bianchi Porro G, Pace F. Comparison of three methods of intraesophageal pH recordings in the diagnosis of gastroesophageal reflux. Scand J Gastroenterol. 1988;23:743–750
  74. Hong SK, Vaezi MF. Gastroesophageal reflux monitoring: pH (catheter & capsule) and impedance. Gastrointest Endoscopy Clin N Am. 2009;19:1–22
  75. Bredenoord AJ, Weusten BLAM, Timmer R, Smouth AJPM. Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol. 2005;100:265–269
  76. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–685
  77. Kahrilas PJ, Quigley EMM. American Gastroenterological Association medical position statement: guidelines on the use of esophageal pH recording. Gastroenterology. 1996;110:1981–1996
  78. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastroesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid and gas reflux. Gut. 2004;53:1024–1031
  79. Hemmink GJM, Bredenoord AJ, Weusten BLAM, et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: “on” or “off” proton pump inhibitor?. Am J Gastroenterol. 2008;103:2446–2453
  80. Pritchett JM, Aslam M, Slaughter JC, et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7:743–748
  81. Schneider JH, Kramer KM, Konigsrainer A, Granderath FA. Ambulatory pH: monitoring with a wireless system. Surg Endosc. 2007;21:2076–2080
  82. Lacy BE, O'Shana T, Hynes M, et al. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Am J Gastroenterol. 2007;102:24–32
  83. Pandolfino JE, Schreiner MA, Lee TJ, et al. Comparison of the Bravo wireless and Digitrapper catheter-based pH monitoring systems for measuring esophageal acid exposure. Am J Gastroenterol. 2005;100:1466–1476
  84. Wong WM, Bautista J, Dekel R, et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring—a randomized trial. Aliment Pharmacol Ther. 2005;21:155–163
  85. Pandolfino JE, Richter JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003;98:740–749
  86. Scarpulla G, Camilleri S, Galante P, et al. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol. 2007;102:2642–2647
  87. Lacy BE, Dukowicz AC, Paquette L, et al. Clinical utility of the Bravo capsule. Am J Gastroenterol. 2007;102:S144–S145
  88. Lee WC, Yeh YC, Lacy BE, et al. Timely confirmation of gastroesophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations. Curr Med Res Opin. 2008;24:1317–1327
  89. Fass R, Ofman JJ, Sampliner RE, et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnostic gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther. 2000;14:389–396
  90. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998;115:42–49
  91. Bate CM, Riley SA, Chapman RWG, et al. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:59–66
  92. Juul-Hansen P, Rydning A, Jacobsen CD, Hansen T. High-dose proton-pump inhibitors as a diagnostic test of gastro-esophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol. 2001;36:806–810
  93. Pandak WM, Arezo S, Everett S, et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol. 2002;35:307–314
  94. Bautista J, Fullerton H, Briseno M, et al. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain—a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 2004;19:1123–1130
  95. Dickman R, Emmons S, Cui H, et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 2005;22:547–555
  96. Metz D, Childs ML, Ruiz C, Weinstein GS. Pilot study of the oral omeprazole test of reflux laryngitis. Otolaryngol Head Neck Surg. 1997;116:41–46
  97. Ours T, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999;94:3131–3138
  98. Kiljander TO, Salomaa ERM, Heitanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000;16:633–638
  99. Fass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis. 2000;18:20–26
  100. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518–527

 Funding: None.

 Conflict of Interest: Drs Weiser, Spangler, Vaezi, and Chertoff do not have any potential conflicts of interest to disclose. Dr Lacy has received investigator-initiated, unrestricted funding for clinical research projects from AstraZeneca, Novartis, and Takeda. Dr Fass has received investigator-initiated research funds from AstraZeneca, Wyeth, and Takeda. He serves as a consultant to Takeda, AstraZeneca, Eisai, GlaxoSmithKline, Vecta, Procter & Gamble, Pfizer, Xenoport, and Addex. Dr Richter has served on the speaker's bureaus for AstraZeneca and TAP. Dr Pandolfino has received investigator-initiated research funds from AstraZeneca, Santarus, Medtronics, and Crospon. Dr Rothstein has received investigator-initiated research funds for studies involving the endoscopic treatment of reflux disease from Ethicon, Olympus, and Bard.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(10)00069-0

doi: 10.1016/j.amjmed.2010.01.007

The American Journal of Medicine
Volume 123, Issue 7 , Pages 583-592 , July 2010

Article Tools

* Image Usage & Resolution